Epstein-Barr Virus Might Kick-Start Multiple Sclerosis
Newswise Tue, 02 May 2006 6:22 AM PDT
People with multiple sclerosis carry immune cells that over-react to Epstein-Barr virus. EBV has long been suspected of playing a role in MS, but the mechanism linking it to the disease was poorly understood. The new findings show the culprit may be a population of T cells that helps boost other components of the immune system in response to EBV.

Norton woman hailed for work with Multiple Sclerosis Society Akron Beacon Journal Tue, 02 May 2006 0:39 AM PDT In many ways, people with multiple sclerosis live with uncertainty. They never know when the chronic disease of the central nervous system might flare up and cause a host of problems, ranging from minor numbness and tingling to paralysis.

Epstein-Barr Virus Might Kick-Start Multiple Sclerosis Howard Hughes Medical Institute Mon, 01 May 2006 2:08 PM PDT Researchers have found that patients with multiple sclerosis (MS) carry a population of immune cells that overreact to Epstein-Barr virus.

AAN: Benefits of early MS treatment 'remarkable' Medical Post Online Mon, 01 May 2006 6:16 PM PDT SAN DIEGO | Very early treatment of multiple sclerosis significantly delays the initial progression of the disease, a Canadian-led study presented at the meeting here indicates.

Health Business UPI Tue, 02 May 2006 9:25 AM PDT WASHINGTON, May 2 (UPI) -- Researchers said Monday that some cases of MS may be caused by a strong reaction to the Epstein-Barr virus.

Boxer weighs in to help Ian's MS funds fight The Scotsman Tue, 02 May 2006 4:14 AM PDT TOP boxer Kenny Anderson handed over a signed pair of gloves and Scotland vest ahead of a sold-out charity auction in the Capital next month.

Tech Gear Aids Stroke Victims Red Herring Tue, 02 May 2006 6:14 AM PDT Hanger Orthopedic launches a device to help stroke survivors walk normally again.

Spring babies in suicide link The Scotsman Mon, 01 May 2006 5:57 PM PDT PEOPLE born in spring or early summer are almost 20 per cent more likely to commit suicide than those born at other times of the year, research suggests.

Researchers Discover New Biotechnology For Crafting Pharmaceuticals To Outsmart Disease Science Daily Mon, 01 May 2006 9:02 PM PDT Researchers at UC Santa Barbara have developed a new biotechnology that enables scientists to identify and engineer protease substrates, giving them the means of crafting pharmaceuticals to outsmart disease. Their work, authored by Patrick Daugherty, an assistant professor of Chemical Engineering, and Kevin Boulware, a PhD candidate, are published online today in the Proceedings of the National

European Medicines Agency: CHMP, Initial Marketing Authorisation Applications, 24-27 April 2006 Medical News Today Tue, 02 May 2006 0:05 AM PDT The Committee for Medicinal Products for Human Use (CHMP) adopted positive opinions on initial marketing authorisation applications for:-- Acomplia and Zimulti (rimonabant) from Sanofi-Aventis, for use as adjunct to diet and exercise for the treatment of obese patients or overweight patients with associated risk factors, such as type 2 diabetes or dyslipidaemia... click link for more info.